← Back to all recalls
DRUG RECALLMODERATE
Cinacalcet Hydrochloride Tablets
Cipla is recalling Cinacalcet Hydrochloride Tablets due to the presence of N-Nitroso Cinacalcet above acceptable limits.
What to do
Consult your healthcare provider or pharmacist regarding this recall and to discuss alternative treatment options.
Why it was recalled
CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit
How to identify it
Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India; Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-412-02
Where it was sold
Distributed in US.
Official source
Other recent recalls from Cipla USA, Inc.
Editorial summary by Recall Canary · last updated 2026-06-05 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification